About C2 Pharma
C2 Pharma is a company based in Luxembourg (Luxembourg) founded in 2014 by Andrew Badrot. It operates as a B2B and Wholesale Distribution. C2 Pharma offers products and services including Atropine Sulfate, Bimatoprost, Brimonidine Tartrate, Cyclopentolate Hydrochloride, and Digoxin. C2 Pharma operates in a competitive market with competitors including AnalytiCon Discovery, Magellan BioScience Group, Celtarys, BJ Biochem and Metagreen, among others.
- Headquarter Luxembourg, Luxembourg
- Founders Andrew Badrot
-
Sectors
HealthcareChemicals & Materials
-
Email
***********
-
Phone
*********
-
Website
*********
- Legal Name C-Squared Pharma India Private Limited
- Date of Incorporation 09 Apr, 2019
- Jurisdiction Mumbai, Maharashtra, India
-
Annual Revenue
-
Net Profit
-$3.58 K (USD)76.1as on Mar 31, 2022
-
EBITDA
-$3.01 K (USD)79.92as on Mar 31, 2022
-
Latest Funding Round
-
Investors
-
Employee Count
Employee Count
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of C2 Pharma
C2 Pharma offers a comprehensive portfolio of products and services, including Atropine Sulfate, Bimatoprost, Brimonidine Tartrate, Cyclopentolate Hydrochloride, and Digoxin.
Active ingredient used in pharmaceuticals for eye treatments.
Compound for ophthalmic applications in eye care.
Ingredient for glaucoma and ocular hypertension treatments.
Used in eye examinations and dilation procedures.
Cardiac medication for heart failure management.
Enhanced form of digoxin for improved absorption.
Agent for eye dilation in ophthalmic procedures.
Variant for eye care and related applications.
Treatment for reducing intraocular pressure.
Decongestant for nasal and eye relief.
Local anesthetic for eye surgeries.
Medication for glaucoma eye treatment.
Alternative form for eye condition management.
Agent for pupil dilation in eye exams.
People of C2 Pharma
Unlock access to complete
Funding Insights of C2 Pharma
Investments & Acquisitions by C2 Pharma
Financial Statements - C2 Pharma
C2 Pharma Comparisons
Competitors of C2 Pharma
C2 Pharma operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as AnalytiCon Discovery, Magellan BioScience Group, Celtarys, BJ Biochem and Metagreen, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Natural products chemistry is specialized in by AnalytiCon Discovery.
|
|
| domain | founded_year | HQ Location |
Identifies and develops microbial natural product leads for pharmaceutical and industrial applications
|
|
| domain | founded_year | HQ Location |
Company that develops and commercializes novel fluorescent probes and ligands for fluorescence-based methods in drug discovery
|
|
| domain | founded_year | HQ Location |
Research and development services for sugar derivatives are provided.
|
|
| domain | founded_year | HQ Location |
Develops technologies to harness compounds from natural production.
|
Frequently Asked Questions about C2 Pharma
C2 Pharma was founded in 2014.
C2 Pharma is headquartered in Luxembourg, Luxembourg.
Andrew Badrot is the current CEO of C2 Pharma. They have also founded this company.
C2 Pharma is a pharmaceutical group established in 2014 that specializes in manufacturing and distributing active pharmaceutical ingredients and complex chemical compounds from natural and synthetic sources. It operates through a global network, including locations in Ireland, Luxembourg, USA, Germany, and India. The company focuses on ophthalmic and niche APIs, supporting research, development, and supply chain activities for various partners in the pharmaceutical industry.
C2 Pharma's top competitors include AnalytiCon Discovery, BJ Biochem and Magellan BioScience Group.
C2 Pharma offers Atropine Sulfate, Bimatoprost, Brimonidine Tartrate, Cyclopentolate Hydrochloride, and 6 more products and services.